Business of the House
Debate between Olivia Blake and Lucy Powell(2 months, 2 weeks ago)
Commons ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Lucy Powell
The hon. Lady raises an important technical matter, and I will certainly look into the progress of that statutory instrument. Given that she has such expertise and diligence in this space, she might want to consider going on the Public Accounts Committee or other Committees as those places come up in the coming weeks.
Olivia Blake (Sheffield Hallam) (Lab)
Earlier this week, I met a constituent who was distressed by the fact that Enhertu—which could extend her life by two years—will not be available in England on the NHS. May we have a debate in Government time on the impact of the National Institute for Health and Care Excellence’s new methods of evaluating health technologies, and in particular, the impact on secondary breast cancer of not approving life-extending medicines for NHS use that might have been approved under NICE’s earlier evaluation methods?
Lucy Powell
NICE’s agreement to the use of drugs on the NHS is a very topical issue that comes up in the Chamber, including at business questions, many times over. My hon. Friend might want to raise this issue at Health questions after we return from recess, but I will certainly ensure that the relevant Minister has heard her call today.